The worldwide incidence of thyroid cancer is increasing substantially, almost exclusively
attributable to small papillary thyroid cancers. Increased use of diagnostic imaging is
considered the most likely explanation for this reported rise, but other factors may also be
contributing. The increase in health care expenditures related to managing these
presumably low-risk cancers, without a clear patient benefit, has resulted in a backlash
against the early detection of thyroid cancer. Currently, there is no way to confidently predict …